Method for treating secretions and glands using botulinum toxin
AssigneeAllergan, Inc.
InventorsK. Roger Aoki, Michael W. Grayston, Steven R. Carlson, Judith M. Leon
Life of this patent
Estimating the term…
Abstract
Method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of, Botulinum toxin types A, B, C, D, E, F and G.
Claims12
A method of treating a secretion of a patient, the method comprising the step of administering to the patient an effective amount of Botulinum toxin in order to reduce the secretion, wherein the secretion is sweat.
A method for treating a cholinergic influenced sweat secretion of a human patient, the method comprising the step of administering to a human patient a therapeutically effective amount of botulinum toxin type A in order to reduce the sweat secretion.
A method for treating a gland, the method comprising the step of administering to a gland a botulinum toxin thereby reducing a secretory activity of the gland, wherein the gland is a sweat gland.
A method for treating an excessively secreting sweat gland, the method comprising the step of injecting an excessively secreting, cholinergic nervous system influenced sweat gland or local sweat gland area of a human patient with a therapeutically effective amount of botulinum toxin type A in order to reduce the excessive sweat gland secretion.
Dependencies are inferred from the claim text.